APA (7th ed.) Citation

Heydari, A. H., Fathi, M., Heydari, S., & Heidari, M. E. (2022, January). Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2. Cardiovascular Therapeutics.

Chicago Style (17th ed.) Citation

Heydari, Amir Hossein, Mojtaba Fathi, Sophia Heydari, and Mohammad Esmaeil Heidari. "Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2." Cardiovascular Therapeutics Jan. 2022.

MLA (9th ed.) Citation

Heydari, Amir Hossein, et al. "Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2." Cardiovascular Therapeutics, Jan. 2022.